IDefine
IDefine is a nonprofit organization dedicated to discovering life-changing treatments and cures for those with intellectual disabilities stemming from genetic disorders.
Donate Now Double the Donation
  • About IDefine
    • Our Story
    • Our Mission
    • Our Team
  • Caregiver Community
    • Newly Diagnosed
    • What is Kleefstra Syndrome
    • Family by Fate
    • Worldwide Map
    • The Kleefstra Clinic
    • Resources
  • Research
    • Our Purpose
    • Clinical Advisory Board (CAB)
    • Scientific Advisory Board (SAB)
    • Research Funding
    • Funding Opportunities
    • For Researchers
  • Fundraise for Research
  • News + Events
    • Conferences
    • IDefine Blog
  • Store
  • About IDefine
    • Our Story
    • Our Mission
    • Our Team
  • Caregiver Community
    • Newly Diagnosed
    • What is Kleefstra Syndrome
    • Family by Fate
    • Worldwide Map
    • The Kleefstra Clinic
    • Resources
  • Research
    • Our Purpose
    • Clinical Advisory Board (CAB)
    • Scientific Advisory Board (SAB)
    • Research Funding
    • Funding Opportunities
    • For Researchers
  • Fundraise for Research
  • News + Events
    • Conferences
    • IDefine Blog
  • Store
IDefine
Donate Now
IDefine Blog
Categories
ALL
ALL CSO CornerIDefine NewsUncategorized

Family by Fate: The Landstroms’ Kleefstra Syndrome Journey

IDefine News  - July 20, 2025

CSO Corner Volume 12: Watching Things Come Together on the Clinical Side

CSO Corner | IDefine News  - June 17, 2025

A Historic Step Forward: IDefine Approves $300,000 for Natural History Study with Boston Children’s Hospital

IDefine News  - March 22, 2025

CSO Corner Volume 10: Establishing the Natural History of Kleefstra Syndrome

CSO Corner  - October 27, 2024
IDefine
IDefine is a nonprofit organization dedicated to discovering life-changing treatments and cures for those with intellectual disabilities stemming from genetic disorders.
Privacy Policy
Connect with us.
Facebook Icon Instagram Icon Twitter Icon LinkedIn Icon YouTube Icon
© 2025 IDefine. All rights reserved.